XML 104 R82.htm IDEA: XBRL DOCUMENT v3.3.1.900
Business Combinations and Contingent Consideration - Acquisition-Date Fair Value of Consideration Transferred (Detail) - USD ($)
$ in Thousands
1 Months Ended
Mar. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Business Acquisition [Line Items]      
Ligand Contingent Consideration   $ 5,227 $ 4,901
Captisol-enabled, propylene glycol-free melphalan rights [Member]      
Business Acquisition [Line Items]      
Cash consideration $ 3,000    
Ligand Contingent Consideration 4,700    
Total purchase consideration $ 7,700